Global Assets Advisory’s Amgen AMGN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q2
$1.42M Buy
3,946
+270
+7% +$92.4K 0.31% 85
2026
Q1
$1.29M Buy
3,676
+238
+7% +$84.8K 0.37% 59
2025
Q4
$1.13M Buy
3,438
+119
+4% +$37.7K 0.32% 72
2025
Q3
$937K Buy
3,319
+389
+13% +$113K 0.28% 89
2025
Q2
$851K Buy
2,930
+155
+6% +$43.9K 0.33% 76
2025
Q1
$813K Buy
2,775
+1,703
+159% +$503K 0.15% 125
2024
Q4
$278K Sell
1,072
-1,523
-59% -$452K 0.15% 125
2024
Q3
$831K Buy
2,595
+1,717
+196% +$562K 0.46% 56
2024
Q2
$274K Sell
878
-215,082
-100% -$63.2M 0.44% 47
2024
Q1
$763K Buy
+215,960
New +$63.2M 0.03% 270

Other funds holding AMGN

Global Assets Advisory's AMGN Position: Q2 2026 in Review

Global Assets Advisory increased its Amgen (AMGN) stake by 7.3% in Q2 2026, buying an estimated $92.4K and bringing the position to 3,946 shares worth $1.42M. The position accounts for 0.31% of the portfolio, ranked #85.

Global Assets Advisory first reported a position in AMGN in Q1 2024 and has held it in 10 quarters since. 3,139 funds tracked by Wall St. Rank hold AMGN as of Q2 2026.

  • Global Assets Advisory held 3,946 shares of Amgen worth $1.42M as of Q2 2026.
  • Global Assets Advisory bought 270 Amgen shares in Q2 2026, an estimated $92.4K.
  • Amgen made up 0.31% of Global Assets Advisory's portfolio in Q2 2026, its #85 holding.
  • Global Assets Advisory first reported a position in Amgen in Q1 2024 and has held it in 10 quarters since.
  • 3,139 funds tracked by Wall St. Rank held Amgen as of Q2 2026.

Based on Global Assets Advisory's 13F filing for Q2 2026, filed 27 Jul 2026.